Zidovudine should be used with caution in patients with severe kidney disease. Dose adjustment of Zidovudine may be needed. Please consult your doctor.

Zidovudine belongs to a group of medications called nucleoside analogue reverse transcriptase inhibitors (NRTIs), also known as antiretrovirals. Zidovudine does not cure HIV infection; it reduces the amount of viruses in the body by inhibiting the chemical (viral reverse transcriptase) which is essential for the virus to grow. Further, Zidovudine also increases some white blood cells (CD4 cells) of the body that are important in fighting infections.
The information given above is for Zidovudine which is the active ingredient of Zidovudine.

Zidovudine may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.